What is the recommended starting dose and titration schedule of lisinopril in adults with impaired renal function based on creatinine clearance?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lisinopril Renal Dosing

For patients with impaired renal function, lisinopril requires dose reduction based on creatinine clearance: no adjustment needed if CrCl >30 mL/min; reduce initial dose to 50% (2.5-5 mg daily) if CrCl 10-30 mL/min; and start at 2.5 mg daily for hemodialysis patients or CrCl <10 mL/min, with maximum titration to 40 mg daily as tolerated. 1

Dosing by Creatinine Clearance

Normal to Mild Renal Impairment (CrCl >30 mL/min)

  • No dose adjustment required 1
  • Standard starting doses apply:
    • Hypertension: 10 mg once daily (or 5 mg if on diuretics) 1
    • Heart failure: 5 mg once daily (or 2.5 mg if hyponatremic with sodium <130 mEq/L) 1
    • Post-MI: 5 mg initially, then 5 mg at 24 hours, 10 mg at 48 hours, then 10 mg daily 1

Moderate Renal Impairment (CrCl 10-30 mL/min)

  • Reduce initial dose to 50% of standard dose 1
    • Hypertension: Start at 5 mg once daily 1
    • Heart failure: Start at 2.5 mg once daily 1
    • Post-MI: Start at 2.5 mg once daily 1
  • Titrate upward as tolerated to maximum 40 mg daily 1
  • Accumulation is highly correlated with creatinine clearance in this range 2
  • Effective half-life doubles compared to normal renal function 2

Severe Renal Impairment (CrCl <10 mL/min or Hemodialysis)

  • Start at 2.5 mg once daily regardless of indication 1
  • Titrate cautiously to maximum 40 mg daily as tolerated 1
  • Significant drug accumulation occurs at this level of renal impairment 3, 4
  • Effective half-life triples compared to normal renal function 2
  • Peak concentrations are higher and time to peak is extended 2

Monitoring Requirements

Initial Monitoring

  • Check renal function and serum potassium within 1-2 weeks of initiation or dose increase 5
  • Baseline assessment before starting therapy is essential 5

Ongoing Monitoring

  • Renal function tests every 3 months during chronic therapy if on ACE inhibitors 5
  • More frequent monitoring (days to 2 weeks) when making dose adjustments 5
  • Minimum 6-monthly monitoring for stable patients 5

Critical Thresholds

  • Discontinue if potassium ≥6 mmol/L 5
  • Reduce dose if serum creatinine increases >30% or eGFR decreases >25% from baseline 5
  • If lesser degree of renal deterioration occurs, recheck in 1-2 weeks but do not reduce dose unless above thresholds are exceeded 5

Clinical Pharmacology Considerations

Drug Accumulation

  • Lisinopril accumulation is highly correlated with creatinine clearance 2
  • Steady state is achieved in 2-3 days with normal renal function, but accumulation occurs with CrCl ≤30 mL/min 3
  • Despite accumulation in severe renal failure, excessive antihypertensive effects do not necessarily occur 4

Efficacy in Renal Impairment

  • Blood pressure reduction occurs across all levels of renal function over 24 hours 2, 4
  • ACE activity is suppressed to <10% of baseline from 4-24 hours after dosing in all renal function groups 4
  • Proteinuria may decrease with appropriate dosing (e.g., from 3.9 to 2.7 g per 24 hours) 6
  • Overall GFR typically remains stable during treatment when appropriately dosed 7

Important Caveats

Hyperkalemia Risk

  • Risk increases with concomitant use of higher ACE inhibitor doses (lisinopril ≥10 mg daily) 5
  • Avoid potassium supplements or reduce them when initiating lisinopril 5
  • Avoid NSAIDs and COX-2 inhibitors which increase hyperkalemia risk 5
  • Risk is particularly elevated in patients with diabetes requiring insulin 5

Hypotension Management

  • If systolic BP drops to ≤100 mmHg, reduce to 5 mg daily maintenance dose 1
  • If prolonged hypotension occurs (systolic BP <90 mmHg for >1 hour), withdraw lisinopril 1
  • Initial hypotension does not preclude careful subsequent titration after effective hypotension management 1

Pediatric Considerations

  • Not recommended in children <6 years or with GFR <30 mL/min/1.73m² 1
  • For children ≥6 years with GFR >30 mL/min/1.73m²: start at 0.07 mg/kg once daily (maximum 5 mg), titrate to maximum 0.61 mg/kg (up to 40 mg) once daily 1

References

Related Questions

Is Lisinopril (ACE inhibitor) suitable for treating hypertension in patients with impaired renal function (high creatinine levels)?
How should Lisinopril (Angiotensin-Converting Enzyme (ACE) inhibitor) be used in patients with Impaired Renal (kidney) Function?
Can a patient with impaired renal function (creatinine level of 1.4) stay on lisinopril (angiotensin-converting enzyme inhibitor)?
At what level of impaired renal function is lisinopril (angiotensin-converting enzyme inhibitor) contraindicated?
Is elevated creatinine (Impaired renal function) a contraindication to lisinopril (angiotensin-converting enzyme inhibitor)?
What is the recommended management of thyroid disease in a pregnant woman?
How do I calculate creatinine clearance using the Cockcroft‑Gault equation (including sex and obesity adjustments) to determine if nitrofurantoin is appropriate?
Which anti‑tuberculosis drug commonly causes red‑orange discoloration of urine?
Why are a comprehensive metabolic panel, complete blood count, serum prolactin, liver function tests, and creatine kinase recommended for evaluating complications of untreated hypothyroidism?
What are the recommended treatment options for an adult with osteoporosis, such as a post‑menopausal woman or older man?
In a first‑trimester pregnant woman with severe hyperemesis gravidarum (weight loss >5%, dehydration, electrolyte disturbances) and biochemical hyperthyroidism (elevated free T4/T3, suppressed TSH) but no overt hyperthyroid symptoms, how should I manage her—fluid resuscitation, anti‑emetics, thiamine, beta‑blocker use, and the role of antithyroid drugs?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.